Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURLY trial of cefalexin duration for febrile urinary tract infection in children
ISRCTN65844003Phase 4Recruiting
- Sponsor
- University of Birmingham
- Start
- Oct 2023
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of cefalexin in urinary tract infection (UTI) (5 arms), sponsored by University of Birmingham. Primary endpoint: Clinical UTI cure rate. Started Oct 2023; status: recruiting.
02
Drugs
cefalexin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ISRCTN65844003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN65844003.